Note 8—Debt

The Company’s debt and borrowing arrangements consist of:

December 31,

December 31,

2025

2024

(Dollars in thousands)

Short-term borrowings

$

199,000 

$

Senior debt:

Senior notes due 2025

$

$

100,000 

Senior notes due 2030

200,000 

Repurchased notes

(3,579)

Debt issuance costs

(3,747)

(207)

Senior debt, net

$

196,253 

$

96,214 

Subordinated debentures

$

13,401 

$

13,401 

Other long-term borrowings

$

13,712 

$

14,081 

Assets pledged as collateral that are not available to pay the Company’s general obligations as of December 31, 2025 consisted of $4.68 billion of loans held for investment at amortized cost and $257.3 million of investment securities that were pledged for short-term-borrowing agreements. In addition, there were $13.7 million of loans held for investment at amortized cost that were pledged for long-term borrowings at December 31, 2025.

Short-term borrowings

The FHLB and FRB lines are periodically utilized to manage liquidity. The amount of loans and securities pledged varies and the collateral may be unpledged at any time to the extent the collateral exceeds advances. As of December 31, 2025, based on the amount of loans and securities pledged, as outlined above, total capacity was $3.39 billion, there was $199.0 million borrowed and $3.19 billion available capacity.

Senior Debt

On August 18, 2025, the Company completed the offering and sale of $200.0 million aggregate principal of 7.375% Senior Notes due 2030 (the “Senior Notes due 2030”). The notes mature on September 1, 2030, and interest is payable semi-annually in arrears on March 1 and September 1 each year. The notes are redeemable in whole or in part beginning on or after the 30th day prior to the maturity date. The Senior Notes due 2030 are the Company’s direct, unsecured and unsubordinated obligations and rank in equal priority with all of the Company’s existing and future unsecured and unsubordinated indebtedness, and senior in right of payment to all the Company’s existing and future subordinated indebtedness.

In August 2025, the Company used the proceeds of this issuance to repay at maturity the outstanding principal of the 4.75% Senior Notes due 2025 (the “Senior Notes due 2025”). The remainder of the net proceeds were used to fund the Company’s share repurchase program and for general corporate purposes.

Subordinated Debentures

As of December 31, 2025, the Company held two statutory business trusts: The Bancorp Capital Trust II and The Bancorp Capital Trust III (the “Trusts”). In each case, the Company owns all the common securities of the Trust. The Trusts issued preferred capital securities to investors and invested the proceeds in the Company through the purchase of junior subordinated debentures issued by the Company (the “2038 Debentures”). The 2038 Debentures are the sole assets of the Trusts. The $10.3 million of 2038 Debentures issued to The Bancorp Capital Trust II and the $3.1 million of 2038 Debentures issued to The Bancorp Capital Trust III were both issued on November 28, 2007, mature on March 15, 2038 and bear interest at the Secured Overnight Financing Rate (“SOFR”) plus 3.51%.

As of December 31, 2025, the Trusts qualify as VIEs under ASC 810, Consolidation. However, the Company is not considered the primary beneficiary and, therefore, the Trusts are not consolidated in the Company’s consolidated financial statements. The Trusts are accounted for under the equity method of accounting.  

Other Long-Term Borrowings

Long-term borrowings consist of sold loans that are accounted for as secured borrowings, because they did not qualify for true sale accounting.

Historical Timeline

Fiscal YearFiled
2025Feb 25, 2026Showing above
2024Mar 3, 2025
2023Feb 29, 2024
2022Mar 1, 2023
2021Mar 1, 2022
2020Mar 15, 2021
2019Mar 16, 2020
2018Mar 15, 2019
2017Mar 16, 2018
2016Mar 16, 2017
2015Mar 15, 2016
2014Sep 28, 2015

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.